PCM
BVS icon

Prelude Capital Management’s Bioventus BVS Stock Holding History

Prelude Capital Management’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243K Buy
25,780
+12,348
+92% +$118K 0.02% 887
2026
Q1 		$123K Sell
13,432
-3,718
-22% -$31.2K 0.01% 1014
2025
Q4 		$128K Buy
17,150
+6,160
+56% +$44.3K 0.01% 1149
2025
Q3 		$73.5K Buy
+10,990
New +$76.3K 0.01% 1081
2025
Q2 		– Sell
-19,916
Closed -$182K – 1032
2025
Q1 		$182K Buy
19,916
+1,682
+9% +$16.8K 0.01% 962
2024
Q4 		$191K Sell
18,234
-8,757
-32% -$104K 0.01% 1008
2024
Q3 		$323K Buy
+26,991
New +$233K 0.02% 828

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Prelude Capital Management's BVS Position: Q2 2026 in Review

Prelude Capital Management increased its Bioventus (BVS) stake by 92% in Q2 2026, buying an estimated $118K and bringing the position to 25,780 shares worth $243K. The position accounts for 0.02% of the portfolio, ranked #887.

Prelude Capital Management first reported a position in BVS in Q3 2024 and has held it in 7 quarters since. The position peaked at $323K in Q3 2024. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Prelude Capital Management held 25,780 shares of Bioventus worth $243K as of Q2 2026.
  • Prelude Capital Management bought 12,348 Bioventus shares in Q2 2026, an estimated $118K.
  • Bioventus made up 0.02% of Prelude Capital Management's portfolio in Q2 2026, its #887 holding.
  • Prelude Capital Management first reported a position in Bioventus in Q3 2024 and has held it in 7 quarters since.
  • Prelude Capital Management's Bioventus position peaked at $323K in Q3 2024.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.